SpendMend Pharmacy

340B Unscripted

Business EN ↓ 110 episodes

Pharmacists and healthcare industry leaders Rob ‘Hoopi’ Nahoopii PharmD, MS, ACE and Greg Wilson PharmD, BCPS, ACE dive deeply into the complicated and contentious 340B Program as well as other pressing Pharmacy matters. Special guests and industry experts pop in frequently to add insights from all sides of the discussion. If you serve in the pharmacy sector, this podcast is a must-listen!

Be sure to visit the podcast's website and support the creator: SpendMend340BUnscripted.podbean.com

Author

SpendMend Pharmacy

Category

Business

Latest episode

Nov 16, 2026

Where to listen?

Podcasts in the app Replaio Radio Coming soon

Podcasts are coming to the app soon. Install now and be the first to see a whole new take on podcasts

Get it on Google Play Install for free Android 10M+ downloads · 4.7+ rating iOS soon

Episodes

Ep 104 | 2027 CMS OPPS and PFS Final Rules & Beckers CPO Conference Recap 16.11.2026

In this episode, Greg and Rob are joined by SpendMend colleague Heidi Larson to recap insights from the recent Beckers Chief Pharmacy Officer Conference in Chicago. In the intro, Rob and Greg discuss major 340B changes coming from the 2027 CMS OPPS and Physician Fee Schedule Final Rules, including Medicare Part B reimbursement cuts, billing modifier requirements, changes to provider-based clinic r...

Ep 103 | 340B and the 2026 Midterm Elections -What to Watch For 02.11.2026

In this episode, Greg and Rob are joined by a returning guest – Peggy Tighe, principal at Powers Law. She’ll be offering some insights on how a shifting political landscape in Washington, D.C. could impact the 340B community. During the conversation, they’ll discuss the potential fate of various 340B legislative proposals as we head towards the end of 2026, highlight key elections to watch in term...

Ep 102 | Updates on the 340B Rebate Model Pilot 26.10.2026

In this episode, Greg and Rob are joined by SpendMend colleague Nick Gnadt to discuss the current state of the 340B Rebate Model Pilot, which is expected to go into effect in January 2027. They discuss the current timeline of the introduction of the pilot, review the manufacturers and drugs included, and discuss some of the challenges that covered entities can anticipate as it relates to data subm...

Ep 101 | 340B Rebate Model Pilot & Grantee Conference Recap 05.10.2026

In this episode, Greg and Rob are joined by SpendMend colleagues Sabrina Allen and Heidi Larson, who offer insights from the recent 340B grantee conference in Wisconsin.  In the intro, the guys share initial reactions to HRSA’s approval of 340B rebate policies, which are set to go into effect January 1, 2027. HRSA 340B Rebate Model Pilot Program webpage:  https://www.hrsa.gov/opa/340b-model-pilot-...

Ep 100 | Updates in 340B 21.09.2026

Without much fanfare, Greg and Rob celebrate the 100th episode of the 340B Unscripted Podcast. They catch up on hot topics in the 340B space, including going through a rundown of key timelines for various 340B-related changes on the horizon. Email us at 340BUnscripted@spendmend.com with your questions! Register for our upcoming 340B CE Webinar on Thursday, October 1st: https://attendee.gotowebinar...

Ep 99 | 340B Developments & Policy Discussion 07.09.2026

In this episode, healthcare attorneys Joella Roland and Jason Reddish from Powers join to provide commentary on a variety of developments impacting 340B covered entities. They’ll discuss ongoing manufacturer activity, from contract pharmacy restrictions to claim data submission requirements, and how 340B providers have been responding. They’ll also share some opinions on how recent judicial ruling...

Ep 98 | CMS 2027 OPPS Proposed Rule & 340B Implications 25.08.2026

In this episode, Greg and Rob are joined by healthcare attorney Kyle Vasquez to discuss the recently released CMS 2027 OPPS proposed rule. They’ll review key provisions in the policy that could impact 340B hospitals, including significant changes to billing requirements, reimbursement rates, and changes to CMS implementation of provider-based criteria for offsite outpatient departments. Earlier in...

Ep 97 | HRSA 340B Rebate Model & SUSTAIN 340B Act 10.08.2026

In this episode, Greg and Rob cover a couple of hot topics in the 340B community. First, they will discuss the recently published HRSA notice regarding a 340B Rebate Model Pilot Program, which is set to initiate in January 2027. They discuss what the operational changes might look like for covered entities, and identify key upcoming dates in HRSA’s implementation timeline. Then, they discuss the r...

Ep 96 | 340B Coalition Summer Conference Recap 27.07.2026

In this episode, Greg and Rob recap highlights from this year's 340B Coalition Summer Conference in Washington, D.C. Comments or questions?  Email us at 340BUnscripted@spendmend.com

Ep 95 | 340B in 2026 – Midyear Review 12.07.2026

In this episode, Greg and Rob are joined by Ted Slafsky and Will Newton of 340B Report. They recap major developments in the first half of 2026 that have impacted the 340B community. They’ll discuss recent Congressional activity, including a newly introduced 340B Program reform bill (SECURE 340B Act), trends in federal administrative agency policies from HRSA and CMS, and the evolution of various...

Ep 94 | Updates on GPO Prohibition – Conversation with Emily Cook 29.06.2026

In this episode, Greg and Rob are joined by returning guest, healthcare attorney Emily Cook. They discuss a recent court ruling (Premier v HHS) that vacated HRSA’s 2013 GPO Prohibition policy notice that addresses compliance with inventory replenishment models, covering insights into the court’s opinion, what it means in terms of potential process changes for covered entities, and compliance consi...

Ep 93 | 340B Patient Definition 15.06.2026

Rob and Greg are joined by healthcare attorney Mark Ogunsusi to discuss 340B patient definition, including the 1996 HRSA guidance, key regulatory developments over the years, and the impact that recent litigation might have on enforcement of this standard. 

Ep 92 | Latest 340B Updates 18.05.2026

In this week’s episode, Greg and Rob discuss developments across the 340B community, including new manufacturer claims level data submission policies and ongoing discussion in Congress on 340B Program reform. Questions or comments? Email us at 340BUnscripted@spendmend.com!

Ep 91 | More 340B Updates 04.05.2026

In this episode, Greg and Rob catch up on more recent developments across the 340B community. They discuss recent Congressional activity where 340B has been a focus, a shift in court rulings related to state contract pharmacy laws, and they catch up on recent litigation over 340B child site eligibility timing, GPO Prohibition policies, and patient definition. They round out the discussion by recap...

Ep 90 | 340B Updates 20.04.2026

In this episode, Greg and Rob catch up on various developments happening in the 340B community. Topics discussed include the proliferation of manufacturer claim submission requirements, notable court rulings and 340B-related lawsuits, and reactions to Congressional hearings that featured testimony related to 340B Program reform considerations. Got questions?  Email us at 340BUnscripted@spendmend.c...

Ep 89 | 340B Pricing Removal & GPO Prohibition Court Case Ruling 06.04.2026

In this episode, Greg and Rob discuss reports of 340B pricing removal from wholesaler accounts, which may be related to recent manufacturer claim submission requirement policies.  They also catch up on some developments in state-level contract pharmacy laws, including Washington’s newly passed state law that incorporates contract pharmacy provisions, as well as reporting requirements for both prov...

Ep 88 | Hospital Child Sites – Recent Developments with CMS Provider-Based Rules and 340B Child Site Eligibility Timing 16.03.2026

In this episode, Greg and Rob are joined by returning guest, healthcare attorney Jeff Davis. They’ll be discussing the CMS provider-based rule changes coming out of the 2026 Consolidated Appropriations Act, including the impact that these changes will have on 340B hospitals. They’ll also share some initial reactions to the Albany Medical Health System v. HHS court ruling out of the DC District Cou...

Ep 87 | HRSA 340B Rebate Request For Information (RFI) 10.03.2026

In this episode, Greg and Rob are joined again by healthcare attorney Todd Nova to discuss the recent HRSA Request For Information (RFI) related to a potential future 340B rebate model pilot. They discuss the nature of the info requested by HRSA in the RFI, thoughts around including confidential/sensitive information in responses, and general strategies for providing constructive feedback to HRSA...

Ep 86 | Updates in 340B 02.03.2026

In this episode, Greg and Rob catch up on various looming deadlines for 340B providers.  That includes submitting responses to the HRSA 340B Rebate Request For Information (RFI), as well as submitting drug purchasing data for the CMS ODACS.   Additionally, they talk about struggles with the 340B/MFP reconciliation process and manufacturer policies requiring claims submission.   As referenced in th...

Ep 85 | HRSA Information Collection Request – 340B Enrollment, Registration & Recertification 02.02.2026

In this episode, Greg and Rob are joined again by healthcare attorney Emily Cook. They discuss a recent HRSA Information Collection Request (ICR) that describes some changes being made to the 340B enrollment, registration and recertification processes. They also discuss recent industry observations around hospital disproportionate share percentage calculations and impact on 340B Program eligibilit...

Ep 84 | CMS OPPS Drug Acquisition Cost Survey (ODACS) 26.01.2026

In this episode, Rob and Greg are joined by guest Andy Ruskin, healthcare attorney and government payer expert from K&L Gates. They’ll be discussing the 2026 CMS OPPS Final Rule, focusing on the provision related to the ODACS, or Outpatient Drug Acquisition Cost Survey. They’ll review the statutory landscape surrounding the survey, recap past attempts by CMS to lower 340B hospital reimbursemen...

Ep 83 | 340B Rebates Are on Hold 12.01.2026

In this episode, Greg and Rob share some initial reactions around the recent judicial activity affecting HRSA's 340B rebate model. They'll discuss thoughts on the federal court ruling that halted the rebate model from going into effect, and also debate what the fallout could be for manufacturers and covered entities given the lack of a regulated deduplication process for MFP and 340B prices. They'...

Ep 82 | Recap of 340B Developments from 2025 22.12.2025

In this episode, Greg and Rob recap key developments in the 340B space from 2025.  They’ll discuss the flurry of activity in recent months related to 340B rebates, project the impact of the OBBB on DSH hospitals, share insights from HRSA audit trends over the last year, and offer commentary on one of the few high points for 340B providers this year – state legislative activity. Also, Rob offers a...

Ep 81 | 340B Rebate Q&A with Beacon 08.12.2025

In this episode, Greg and Rob are joined by Katheryne Richardson of the Beacon team, to discuss frequently asked questions about the upcoming 340B rebate model.  They’ll cover the differences between Beacon applications, commonly asked questions regarding data submission, and tips for covered entities to consider as the implementation date approaches. Come see us at Booth #1545 during this year’s...

Ep 80 | 340B Updates, including CMS CY26 OPPS Final Rule and Rebate Developments 01.12.2025

In this episode, Greg and Rob catch up on some clarifications gained around the upcoming 340B rebate model, including purchasing requirements and developments with select chain retail pharmacies updating their policies. Additionally, they discuss the CMS CY2026 OPPS final rule that was just published, including potential implications for 340B hospitals. CMS Hospital Drug Acquisition Cost Survey In...

Listen to the 340B Unscripted podcast in Replaio

Radio and podcasts in one app - free, with no sign-up. Install today and do not miss the launch

Get it on Google Play

Replaio is not a podcast publisher; show names, artwork and audio belong to their authors and are distributed through public RSS feeds.